Neoadjuvant treatment with tyrosine kinase inhibitors in patients with resectable non-small cell lung cancer

Antzeko izenburuak

• Use of a tyrosine kinase inhibitor as neoadjuvant therapy for non-small cell lung cancer: A case report
  nork: López-González, A., et al.
  Argitaratua: (2013)
• Prognostic factors in potentially resectable stage III non-small cell lung cancer receiving neoadjuvant treatment—a narrative review
  nork: Calvo, Virginia, et al.
  Argitaratua: (2021)
• Brain metastases in resected non-small cell lung cancer: The impact of different tyrosine kinase inhibitors
  nork: Yun, Po-Jen, et al.
  Argitaratua: (2019)
• Neoadjuvant chemoimmunotherapy in resectable stage IIIA/IIIB non-small cell lung cancer
  nork: Chen, Yulong, et al.
  Argitaratua: (2021)
• Targeting Angiogenesis with Multitargeted Tyrosine Kinase Inhibitors in the Treatment of Non-Small Cell Lung Cancer
  nork: Scagliotti, Giorgio, et al.
  Argitaratua: (2010)